BIOMAT Database Logo BIOMAT Database Logo

Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. 2007

E Leuridan, and P Van Damme
Centre for the Evaluation of Vaccination, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk, Belgium. elke.leuridan@ua.ac.be

This paper reviews literature on passively transferred maternal antibodies against measles in infants. The amount and decay of these antibodies can be a result of changing patterns in society: increasing cohorts of women are vaccinated against measles instead of having naturally acquired immunity, the age of first childbirth is increasing and young adults are less exposed to natural boosters. The concentration and persistence of maternal antibodies differ in infants of women vaccinated against measles versus infants of naturally immune women. The date for commencing universal measles vaccination should take into account the presence of these antibodies since they can hamper the immunological response to vaccination. Each country should therefore consider adapting the timing of vaccination in relation to its measles sero-epidemiological situation. The possibility of priming the immune system with an early vaccine dose and boosting later on offers opportunities for vaccination at very young age.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

E Leuridan, and P Van Damme
[Loss of maternal measles antibodies acquired by vaccination against measles].
May 1991, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
E Leuridan, and P Van Damme
Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
December 2003, Medical science monitor : international medical journal of experimental and clinical research,
E Leuridan, and P Van Damme
Naturally Acquired Antibodies against Plasmodium falciparum: Friend or Foe?
July 2021, Pathogens (Basel, Switzerland),
E Leuridan, and P Van Damme
Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
November 1999, Clinical and diagnostic laboratory immunology,
E Leuridan, and P Van Damme
[Rinderpest protection induced in cattle by measles vaccine. Application to calves with passive immunity by maternal antibodies].
January 1968, Revue d'elevage et de medecine veterinaire des pays tropicaux,
E Leuridan, and P Van Damme
Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India.
October 2007, Clinical and vaccine immunology : CVI,
E Leuridan, and P Van Damme
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
January 2015, Human vaccines & immunotherapeutics,
E Leuridan, and P Van Damme
Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus.
July 1990, Biologicals : journal of the International Association of Biological Standardization,
E Leuridan, and P Van Damme
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis.
January 2021, Frontiers in immunology,
E Leuridan, and P Van Damme
Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.
April 2004, Infection and immunity,
Copied contents to your clipboard!